At the news
? NEUTRALIMPACT 2/10 144 filed Jun 18, 2026 at 16:23 ET
Director Karin Eastham filed a Form 144 notice of intent to sell 3,729 shares of Veracyte common stock, valued at approximately $191,260, from vested restricted stock units. This is a routine insider sale for tax or diversification purposes and carries no material signal about company fundamentals.
- Insider: Director Karin Eastham
- Shares to be sold: 3,729 shares of common stock
- Estimated value: $191,260.41
- Source of shares: Restricted stock units (vested)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access